Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Telecom & IT > RFID > European Markets for RFID in Pharmaceuticals
Category
Telecom & IT (11444)
Broadband (398)
Contact Centers (152)
Contents (612)
Convergence (197)
Data Center (351)
Digital Broadcasting (309)
E-commerce (204)
IT Outsourcing (321)
IT Security (495)
LBS (150)
Mobile Device (721)
Mobile Subscribers (128)
Network (632)
Network & Access Devices (256)
Next Generation Wireless Com (538)
NFC (148)
Online Marketing (138)
Operator Company Profile (766)
Optical Network (266)
RFID (250)
Satellite Telecom (130)
Set-Top Box (61)
Software (1025)
UC (299)
Web-Service (487)
Wireless LAN/WiMAX (547)
Market Research Report

European Markets for RFID in Pharmaceuticals

Published by Frost & Sullivan
Published December, 2006 Product code 47610
Content info 32 Pages
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Markets for RFID in Pharmaceuticals published by Frost & Sullivan in December, 2006. This report consists of 32 Pages and the price starts from US $ 6500.

Introduction

Abstract

The European Markets for RFID in Pharmaceuticals focusses on the emerging market for RFID applications in the pharmaceutical industry. It focusses on the key drivers, restraints and challenges faced by RFID vendors and pharmaceutical companies. The research also gives a forecast of the total revenues from the pharmaceutical industry till 2012. It also gives a strategic road map to adoption of RFID and technology trends for a successful implementation of the technology.

Table of Contents

1. Executive Summary

  • 1. Market Overview
    • 1. Introduction
    • 2. Market Definition

2. Glossary

  • 1. Appendix
    • 1. Terms and Definitions

3. Market Challenges

  • 1. Key Challenges
    • 1. Challenges Affecting the RFID Market

4. Total European Market for RFID in Pharmaceuticals

  • 1. Overview and Definitions
    • 1. Introduction
    • 2. Market Drivers
      • a. Increase in Drug Counterfeiting to Make RFID Adoption Imperative
      • b. Benefits Across the Supply Chain to Compel Investment in RFID
      • c. Early Users to Set a Precedent
      • d. Cold Chain Compliance to Drive RFID Spend
      • e. Success in Other Verticals to Have a Spill Over Effect
      • f. Passive Tags and High Priced Drugs to Yield Good ROIs
      • g. The Bollini Law
    • 3. Market Restraints
      • a. Cost Effectiveness of RFID Deployment
      • b. Trading Partner Adoption Level
      • c. Technological Glitches Proving to be a Stumbling Block
      • d. Existing Investments in Bar Code Technology
      • e. Effect of RF Radiation on Drugs
    • 4. Market Engineering Measurements
    • 5. Revenue Forecasts
    • 6. Key Initiatives by Vendors and Pharmaceutical Companies
  • 2. Trends Analysis
    • 1. Demand Analysis
    • 2. Technology Trends

5. Recommendations and Conclusion

  • 1. Strategic Recommendations and Conclusions
    • 1. Strategic Recommendations
    • 2. Conclusion

6. Database of Key Industry Participants

  • 1. Industry Participants
    • 1. List of Key Industry Participants
Back to Top